# Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.

> **NCT01703728** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 455 (actual)

## Conditions studied

- Ovarian Hyperstimulation Syndrome (OHSS)

## Interventions

- **OTHER:** Highly purified menotropin (HP- hMG) treatment

## Key facts

- **NCT ID:** NCT01703728
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703728, "Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01703728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*